bims-cytox1 Biomed News
on Cytochrome oxidase subunit 1
Issue of 2023–04–02
two papers selected by
Gavin McStay, Liverpool John Moores University



  1. bioRxiv. 2023 Mar 22. pii: 2023.03.20.530986. [Epub ahead of print]
      Cytochrome c oxidase (C c O) is an essential enzyme in mitochondrial and bacterial respiration. It catalyzes the four-electron reduction of molecular oxygen to water and harnesses the chemical energy to translocate four protons across biological membranes, thereby establishing the proton gradient required for ATP synthesis 1 . The full turnover of the C c O reaction involves an oxidative phase, in which the reduced enzyme ( R ) is oxidized by molecular oxygen to the metastable oxidized O H state, and a reductive phase, in which O H is reduced back to the R state. During each of the two phases, two protons are translocated across the membranes 2 . However, if O H is allowed to relax to the resting oxidized state ( O ), a redox equivalent to O H , its subsequent reduction to R is incapable of driving proton translocation 2,3 . How the O state structurally differs from O H remains an enigma in modern bioenergetics. Here, with resonance Raman spectroscopy and serial femtosecond X-ray crystallography (SFX) 4 , we show that the heme a 3 iron and Cu B in the active site of the O state, like those in the O H state 5,6 , are coordinated by a hydroxide ion and a water molecule, respectively. However, Y244, a residue covalently linked to one of the three Cu B ligands and critical for the oxygen reduction chemistry, is in the neutral protonated form, which distinguishes O from O H , where Y244 is in the deprotonated tyrosinate form. These structural characteristics of O provide new insights into the proton translocation mechanism of C c O.
    DOI:  https://doi.org/10.1101/2023.03.20.530986
  2. Int J Mol Sci. 2023 Mar 16. pii: 5705. [Epub ahead of print]24(6):
      Mitochondrial metabolism plays an important role in the occurrence and development of cancers. Cytochrome C oxidase assembly factor six (COA6) is essential in mitochondrial metabolism. However, the role of COA6 in lung adenocarcinoma (LUAD) remains unknown. Here we report that the expression of COA6 mRNA and protein were upregulated in LUAD tissues compared with lung normal tissues. We found that COA6 had high sensitivity and specificity to distinguish LUAD tissues from normal lung tissues shown by a receiver operating characteristic (ROC) curve. In addition, our univariate and multivariate Cox regression analysis indicated that COA6 was an independent unfavorable prognostic factor for LUAD patients. Furthermore, our survival analysis and nomogram showed that a high expression of COA6 mRNA was related to the short overall survival (OS) of LUAD patients. Notably, our weighted correlation network analysis (WGCNA) and functional enrichment analysis revealed that COA6 may participate in the development of LUAD by affecting mitochondrial oxidative phosphorylation (OXPHOS). Importantly, we demonstrated that depletion of COA6 could decrease the mitochondrial membrane potential (MMP), nicotinamide adenine dinucleotide (NAD) + hydrogen (H) (NADH), and adenosine triphosphate (ATP) production in LUAD cells (A549 and H1975), hence inhibiting the proliferation of these cells in vitro. Together, our study strongly suggests that COA6 is significantly associated with the prognosis and OXPHOS in LUAD. Hence, COA6 is highly likely a novel prognostic biomarker and therapeutic target of LUAD.
    Keywords:  cytochrome C oxidase assembly factor 6 (COA6); lung adenocarcinoma; mitochondrion; oxidative phosphorylation; prognosis
    DOI:  https://doi.org/10.3390/ijms24065705